The role and diagnostic value of deregulated miRNAs in cervical cancer
Open Access
- 25 May 2025
- journal article
- review article
- Published by Springer Nature in Discover Oncology
- Vol. 16 (1) , 1-22
Abstract
Cervical cancer (CC) remains a significant global health concern, particularly affecting women in low-income countries. Despite advancements in screening programs, CC continues to pose a substantial mortality risk, highlighting the need to explore diagnostic and treatment modalities. This review focuses on the role of deregulated microRNAs (miRNAs) in CC development, emphasizing their potential as biomarkers for early detection and prognosis in body fluids. miRNAs have emerged as critical regulators of key cellular processes, including proliferation, migration, invasion, and apoptosis, and their dysregulation is closely linked to CC progression. Upregulated miRNAs such as miR-146b-3p, miR-1908, and miR-21 promote CC progression by targeting tumor suppressor genes, while downregulated miRNAs like miR-23-3p and miR-4262 are associated with reduced tumor aggressiveness. miRNAs also hold significant promise as non-invasive prognostic biomarkers. Their expression levels correlate with clinical outcomes, including tumor stage, metastasis, and overall survival, making them valuable tools for risk stratification and personalized treatment strategies. Liquid biopsies, which detect circulating miRNAs in bodily fluids, offer a minimally invasive approach to monitor tumor dynamics and predict patient outcomes. Furthermore, exosomal miRNAs are emerging as promising diagnostic and prognostic tools for CC. Advanced diagnostic technologies and bioinformatics tools are anticipated to enhance the identification of evident miRNA biomarkers in the clinical settings. Standardized protocols for sample collection and analysis will improve the reproducibility of miRNA studies, while a deeper understanding of miRNA biology may unlock their potential as therapeutic targets. In conclusion, this review consolidates current research on deregulated miRNAs in CC, highlighting their diagnostic and prognostic significance. The findings underscore the potential of miRNAs to revolutionize CC management through innovative diagnostic and therapeutic strategies.Keywords
Funding Information
- Tabriz University of Medical Sciences (67334)
This publication has 194 references indexed in Scilit:
- Genome-wide analysis of HPV integration in human cancers reveals recurrent, focal genomic instabilityGenome Research, 2013
- miR-196a targets netrin 4 and regulates cell proliferation and migration of cervical cancer cellsBiochemical and Biophysical Research Communications, 2013
- OCT4 promotes tumorigenesis and inhibits apoptosis of cervical cancer cells by miR-125b/BAK1 pathwayCell Death & Disease, 2013
- Circulating miRNA-20a and miRNA-203 for Screening Lymph Node Metastasis in Early Stage Cervical CancerGenetic Testing and Molecular Biomarkers, 2013
- MicroRNA-10a targets CHL1 and promotes cell growth, migration and invasion in human cervical cancer cellsCancer Letters, 2012
- Updating the Natural History of Human Papillomavirus and Anogenital CancersVaccine, 2012
- miR‐20a promotes migration and invasion by regulating TNKS2 in human cervical cancer cellsFEBS Letters, 2012
- miR-143 is downregulated in cervical cancer and promotes apoptosis and inhibits tumor formation by targeting Bcl-2Molecular Medicine Reports, 2011
- Detection of bovine papillomavirus type 2 in the peripheral blood of cattle with urinary bladder tumours: possible biological roleJournal of General Virology, 2008
- The rabbit viral skin papillomas and carcinomas: A model for the immunogenetics of HPV-associated carcinogenesisClinics in Dermatology, 1997